VSIR and cancer: ,30,31 Although rational combination immunotherapy is a promising approach, the interaction of VISTA with other immune checkpoints may differ depending on the cancer type and expression patterns or magnitude of immune modulators, which are complex and diverse, as demonstrated in the present study.